Abstract:The global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated scientists to satisfy an urgent need for a rapid and accurate detection of pathogens. Traditionally, the culture-based technique is considered as the gold standard for pathogen detection, yet it has a long turnaround time due to the overnight culturing and pathogen isolation. Alternatively, nucleic acid amplification tests provide a relatively shorter turnaround time to identify whether pathogens exist in individuals with high sensitivity and high specificity. In most cases, nucleic acid amplification tests undergo three steps: sample preparation, nucleic acid amplification, and signal transduction. Despite the explosive advancement in nucleic acid amplification and signal transduction technologies, the complex and labor-intensive sample preparation steps remain a bottleneck to create a transformative integrated point-of-care (POC) molecular diagnostic device. Researchers have attempted to simplify and integrate the sample preparations for nucleic acid-based molecular diagnostic devices with innovative progress in integration strategies, engineered materials, reagent storages, and fluid actuation. Therefore, understanding the know-how and obtaining truthful knowledge of existing integrated POC molecular diagnostic devices comprising sample preparations, nucleic acid amplification, and signal transduction can generate innovative solutions to achieve personalized precision medicine and improve global health.In this Account, we discuss the challenges of automated sample preparation solutions integrated with nucleic acid amplification and signal transduction for rapid and precise home diagnostics. Blood, nasal swab, saliva, urine, and stool are emphasized as the most commonly used clinical samples for integrated POC molecular diagnostics of infectious diseases. Even though these five types of samples possess relatively correlated biomarkers due to the human body's circulatory system, each shows unique properties and exclusive advantages for molecular diagnostics in specific situations, which are included in this Account. We examine different integrated POC devices for sample preparation, which includes pathogen isolation and enrichment from the crude sample and nucleic acid purification from isolated pathogens. We present the promising on-chip integration approaches for nucleic acid amplification. We also investigate the on-chip integration methods for reagent storage, which is crucial to simplify the manual operation for end-users. Finally, we present several integrated POC molecular diagnostic devices for infectious diseases. The integrated sample preparation and nucleic acid amplification approach reviewed here can potentially impact the next generation of POC molecular home diagnostic chips, which will significantly impact public health, emergency medicine, and global biosecurity.

Point-of-care Technologies for Molecular Diagnostics Using a Drop of Blood.

Portable point-of-care diagnostic devices: an updated review

Integrated Point-of-Care Molecular Diagnostic Devices for Infectious Diseases

Sample preparation and detection methods in point-of-care devices towards future at-home testing

Paper-based Analytical Devices for Point-of-care Blood Tests.

Point-of-care cancer diagnostic devices: From academic research to clinical translation

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

Integrated microfluidic pneumatic circuit for point-of-care molecular diagnostics

Innovations in One-Step Point-of-Care Testing within Microfluidics and Lateral Flow Assays for Shaping the Future of Healthcare

Microfluidics-based strategies for molecular diagnostics of infectious diseases

Microneedle Sensors for Point‐of‐Care Diagnostics

DropLab: an automated magnetic digital microfluidic platform for sample-to-answer point-of-care testing—development and application to quantitative immunodiagnostics

Evidence-based point-of-care diagnostics: current status and emerging technologies

The point-of-care-testing of nucleic acids by chip, cartridge and paper sensors

Molecular Point‐of‐Care Assay Development: Design and Considerations

[Recent Advances in Molecular Point of Care Tests]

Sample Preparation for Lab-on-a-Chip Systems in Molecular Diagnosis: A Review

Point-of-care testing of four chronic disease biomarkers in blood based on a low cost and low system complexity microfluidic chip with integrated oxygen-sensitive membrane

Aspects of Point-of-Care Diagnostics for Personalized Health Wellness

Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing

CMOS Point-of-Care Diagnostics Technologies: Recent Advances and Future Prospects